Recombinant humanized monoclonal antibody to CGRP-I.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG2SA - Human IgG2 with S387A mutation
Light Chains
kappa
Conjugate
Unconjugated
Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
SDS-PAGE analysis of Fremanezumab Biosimilar - Anti-CGRP-I Antibody - Low endotoxin, Azide free (A323461) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Fremanezumab Biosimilar - Anti-CGRP-I Antibody - Low endotoxin, Azide free (A323461) confirms that the purity of this antibody is 100%.
Publishing research using Fremanezumab Biosimilar - Anti-CGRP-I Antibody - Low endotoxin, Azide free (A323461)? Please let us know so that we can list the citation on this page.
Alternative products to Fremanezumab Biosimilar - Anti-CGRP-I Antibody - Low endotoxin, Azide free (A323461)
![Flow Cytometry - Anti-CGRP-I Antibody [7C1] - BSA and Azide free (A324637) - Antibodies.com](https://cdn.antibodies.com/image/catalog/324/A324637_1.jpg?profile=product_alternative)
